Literature DB >> 7740500

The APTT monitoring of heparin--the ISTH/ICSH collaborative study.

E A Van der Velde1, L Poller.   

Abstract

In an international collaborative study three candidate reference and the local APTT reagent have been tested with lyophilized plasmas containing heparin added in vitro and fresh plasmas from heparinized patients to determine whether it was possible to standardize APTT heparin monitoring. The APTT responses of patients with thrombosis were much less to the same concentrations of heparin so only these plasmas were used to calibrate the reagents. A calibration constant (b) was determined for each local APTT system from the orthogonal regression slope of the patients' and normals' plasmas. Although the calibration was based on relatively limited numbers of patients' plasmas the results gave no consistent indication that this method of analysis with the reference preparations was incorrect. Two of the three candidate reference reagents performed almost equally well and one of these reagents is recommended as the APTT reference preparation. Use of a single b value for a brand of reagent for all laboratories is not advised. Each laboratory must perform its own local calibration. The adoption of a reference APTT reagent together with the use of orthogonal regression analysis would be a useful step to initiate APTT heparin monitoring standardization and to develop safe and effective local therapeutic ranges.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7740500

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Bedside coagulometry during intravenous heparin therapy after coronary angioplasty.

Authors:  A P Schroeder; L L Knudsen; S E Husted; L Knudsen; J Ingerslev
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300

2.  Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.

Authors:  Pascale Gaussem; M Dubar; B le Bonniec; I Richard-Lordereau; R Jochemsen; M Aiach
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

3.  Monitoring of the heparinization in the rabbit animal model during endovascular interventions.

Authors:  Anne J Schmitt; Anna K Wallner; Shahrzad Afazel; Monika Killer-Oberpfalzer
Journal:  Neuroradiology       Date:  2013-04-26       Impact factor: 2.804

4.  Population modelling of the effect of inogatran, at thrombin inhibitor, on ex vivo coagulation time (APTT) in healthy subjects and patients with coronary artery disease.

Authors:  M Cullberg; U G Eriksson; M Larsson; M O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.